What is a stock summary page? Click here for an overview.
Business Description
Ferozsons Laboratories Ltd
ISIN : PK0005201014
Compare
Compare
Traded in other countries / regions
FEROZ.Pakistan IPO Date
1960-09-08Description
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 2.68 | |||||
| Interest Coverage | 2.36 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.1 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.3 | |||||
| 3-Year EBITDA Growth Rate | 5.2 | |||||
| 3-Year EPS without NRI Growth Rate | -19.6 | |||||
| 3-Year Book Growth Rate | 14.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.73 | |||||
| 9-Day RSI | 41.67 | |||||
| 14-Day RSI | 41.99 | |||||
| 3-1 Month Momentum % | -5.52 | |||||
| 6-1 Month Momentum % | 9.49 | |||||
| 12-1 Month Momentum % | 37.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.59 | |||||
| Quick Ratio | 0.98 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 201.78 | |||||
| Days Sales Outstanding | 56.43 | |||||
| Days Payable | 105.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.98 | |||||
| Dividend Payout Ratio | 0.19 | |||||
| Forward Dividend Yield % | 0.98 | |||||
| 5-Year Yield-on-Cost % | 0.98 | |||||
| Shareholder Yield % | -16.83 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.88 | |||||
| Operating Margin % | 10.64 | |||||
| Net Margin % | 4.1 | |||||
| FCF Margin % | 3.29 | |||||
| ROE % | 6.71 | |||||
| ROA % | 3.14 | |||||
| ROIC % | 6.93 | |||||
| 3-Year ROIIC % | -1.01 | |||||
| ROC (Joel Greenblatt) % | 13.09 | |||||
| ROCE % | 13.68 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.32 | |||||
| PE Ratio without NRI | 19.32 | |||||
| Shiller PE Ratio | 15.11 | |||||
| PEG Ratio | 1.03 | |||||
| PS Ratio | 0.79 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 1.12 | |||||
| Price-to-Free-Cash-Flow | 24.03 | |||||
| Price-to-Operating-Cash-Flow | 10.93 | |||||
| EV-to-EBIT | 8.76 | |||||
| EV-to-EBITDA | 6.61 | |||||
| EV-to-Revenue | 1.03 | |||||
| EV-to-Forward-Revenue | 0.5 | |||||
| EV-to-FCF | 31.14 | |||||
| Price-to-GF-Value | 1.03 | |||||
| Price-to-Median-PS-Value | 0.62 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.35 | |||||
| Price-to-Graham-Number | 0.98 | |||||
| Earnings Yield (Greenblatt) % | 11.42 | |||||
| FCF Yield % | 4.17 | |||||
| Forward Rate of Return (Yacktman) % | 8.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ferozsons Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₨) | 16,815.87 | ||
| EPS (TTM) (₨) | 15.85 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.21 | ||
| 3-Year Sortino Ratio | 0.35 | ||
| Volatility % | 35.84 | ||
| 14-Day RSI | 41.99 | ||
| 14-Day ATR (₨) | 9.66399 | ||
| 20-Day SMA (₨) | 308.7315 | ||
| 12-1 Month Momentum % | 37.35 | ||
| 52-Week Range (₨) | 218 - 393 | ||
| Shares Outstanding (Mil) | 43.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ferozsons Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ferozsons Laboratories Ltd Stock Events
| Event | Date | Price (₨) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ferozsons Laboratories Ltd Frequently Asked Questions
What is Ferozsons Laboratories Ltd(KAR:FEROZ)'s stock price today?
The current price of KAR:FEROZ is ₨306.16. The 52 week high of KAR:FEROZ is ₨393.00 and 52 week low is ₨218.00.
When is next earnings date of Ferozsons Laboratories Ltd(KAR:FEROZ)?
The next earnings date of Ferozsons Laboratories Ltd(KAR:FEROZ) is .
Does Ferozsons Laboratories Ltd(KAR:FEROZ) pay dividends? If so, how much?
The Dividend Yield %  of Ferozsons Laboratories Ltd(KAR:FEROZ) is 0.98% (As of Today), Highest Dividend Payout Ratio of Ferozsons Laboratories Ltd(KAR:FEROZ) was 17.36. The lowest was 0.11. And the median was 0.51. The  Forward Dividend Yield % of Ferozsons Laboratories Ltd(KAR:FEROZ) is 0.98%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers